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Abstract. Tenascin-Y was identified in chicken as a 
novel member of the tenascin (TN) family of ECM pro- 
teins. Like TN-C, TN-R, and TN-X, TN-Y is a multido- 
main protein consisting of heptad repeats, epidermal 
growth factor-like repeats, fibronectin type III-like 
(FNIII) domains and a domain homologous to fibrino- 
gen. In contrast to all other known TNs, the series of 
FNIII domains is interrupted by a novel domain, rich in 
serines (S) and prolines (P) that occur as repeated S-P- 
X-motifs, where X stands for any amino acid. Interest- 
ingly, the TN-Y-type FNIII domains are 70-100% iden- 
tical with respect to their DNA sequence. Different 
TN-Y variants are created by alternative splicing of 
FNtlI domains. Although, based on sequence compari- 
sons TN-Y is most similar to mammalian TN-X, these 
molecules are not species homologues. TN-Y is pre- 
dominantly expressed in embryonic and adult chicken 
heart and skeletal muscle and, to a lower extent, also in 
several non-muscular tissues. Two major transcripts of 
~6.5 and 9.5 kb are differentially expressed during 
heart and skeletal muscle development and are also 
present in the adult. Anti-TN-Y antibodies recognize a 
~400-kD double band and a ~300-kD form of TN-Y 
on immunoblots of chicken heart extracts. In situ hy- 
bridization and immunofluorescence analysis of aortic 
smooth muscle, heart, and skeletal muscle revealed that 
TN-Y is mainly expressed and secreted by cells within 
muscle-associated connective tissue. Cultured primary 
muscle fibroblasts released a ~220-kD doublet and a 
~170-kD single TN-Y variant only when cultured in 
10% horse serum but not in medium containing 10% 
fetal calf serum. All TN-Y variants isolated bind to hep- 
arin under physiologically relevant conditions that may 
indicate an important function retained in all tenascins. 
T 
HE  tenascin  (TN)l-family  of  extracellular  matrix 
glycoproteins  currently  counts  three  members  in 
vertebrates: TN-C, TN-R, and TN-X (for review see 
Erickson, 1993; Chiquet-Ehrismann et al.,  1994; Chiquet- 
Ehrismann,  1995, and references therein). They exhibit a 
modular  structure,  typical  for  extracellular  matrix  pro- 
teins,  that  evolved through  the  shuffling  of mobile  do- 
mains. The mechanism of shuffling modules with defined 
subfunctions may have proven to be an efficient mecha- 
nism to create new, multifunctional proteins (Patthy, 1991; 
Bork, 1992; Engel et al., 1994; Doolittle, 1995). 
All tenascins are built of four types of sequence motifs 
which can fold independently into structural  units: 3-3.5 
NH2-terminal heptad repeats, 4.5-18.5  tenascin-type epi- 
dermal  growth  factor (EGF)-like repeats,  a  series  of fi- 
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bronectin type III-like (FNIII) domains, and a fibrinogen- 
like  domain  at  their  COOH  terminus.  The latter  is  the 
most conserved part among all tenascins (Erickson, 1994). 
A portion of FNIII domains called the variable domains is 
subject to alternative splicing that creates various splice 
forms differing in number and combination of their vari- 
able domains. Depending on the species, TN-C has six to 
eight variable domains,  some of which  evolved only re- 
cently by internal gene duplications (Gulcher et al., 1990). 
Only one variable domain has  been identified so far in 
chicken and rat TN-R (N0renberg et al.,  1992; Fuss et al., 
1993) but the cysteine-rich NH2-terminal region of chicken 
TN-R undergoes differential splicing as well (N6renberg 
et al., 1992). TN-X splice variants are produced by differ- 
ent mouse cell lines (Matsumoto et al., 1994) and were re- 
ported to occur in some porcine tissues (Geffrotin et al., 
1995). 
In the case of TN-C, two subunit trimers are disulfide 
linked  to  form  a  six-armed  molecule,  a  hexabrachion 
(Erickson and Iglesias, 1984).  Although TN-R has all the 
features to assemble into a six-armed molecule as well, it 
seems to form trimers, dimers  and monomers only (Pe- 
sheva et al., 1989; N6renberg et al., 1992). The microscopic 
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evidence that TN-X may also assemble into higher order 
structures (Bristow et al., 1993; Matsumoto et al., 1994). 
The search for functional properties of the tenascin pro- 
totype, TN-C, revealed complex effects in modulating cell 
adhesion  and  neurite  outgrowth.  This  turned  out  to  be 
true for TN-R as well, and thus could be a general feature 
of the  tenascins  (reviewed  in  Chiquet-Ehrismann,  1991, 
1993;  Husmann  et  al.,  1995;  Schachner  et  al.,  1994).  In 
vitro studies using recombinant proteins composed of vari- 
ous combinations of TN-C domains helped to assign spe- 
cific functions such as cell binding  activity, anti-adhesive 
activity, or the ability to bind to other extracellular matrix 
molecules  to different  sites  within  TN-C  (Spring  et  al., 
1989;  Prieto et al.,  1992;  Aukhil et al.,  1993;  G6tz et al., 
1996).  Sometimes, results obtained using bacterial as op- 
posed to eukaryotic expression systems are inconsistent. 
Aukhil  et  al.  (1993)  mapped  two  heparin-binding  sites 
within TN-C, whereas Fischer et al. (1995) showed that a 
single region within the fibrinogen globe of TN-C is neces- 
sary and sufficient for binding of the intact protein to hep- 
arin. Since TN-X has also been shown to bind to heparin 
(Matsumoto et al., 1994), this ability may be retained in all 
tenascins, and thus is likely to play an important functional 
role in vivo. Differential expression of TN-C splice forms 
is a subtle way to adapt its in vivo activities to tissue spe- 
cific needs.  It was  shown  that  the  smallest TN-C splice 
variants bind more strongly to fibronectin (Chiquet-Ehris- 
mann et al.,  1991)  and that the presence of alternatively 
spliced FNIII domains induces the loss of focal adhesions 
in endothelial cells (Murphy-Ullrich et al., 1991). 
The interest in TN-C is based on its dynamic expression 
in many developing organs, whereas only a few adult tis- 
sues express TN-C (reviewed in Chiquet-Ehrismann, 1995). 
Expression of TN-R is  restricted  to the central  nervous 
system while TN-X is quite ubiquitously expressed in em- 
bryonic and adult tissues but is most abundant in fetal and 
postnatal  muscle  tissue  and  testis  (Rathjen  et  al.,  1991; 
Bristow et al., 1993; Matsumoto et al., 1994; Geffrotin et al., 
1995).  In a number of tissues, the expression of various te- 
nascins has been observed to overlap. This either indicates 
that  different  functional  properties of the  tenascins  are 
needed or that expression is redundant in a particular tis- 
sue. In this context, the lack of an obvious phenotype in 
mice deprived of TN-C (Saga et al., 1992) deserves further 
investigation, and yet unidentified tenascin-like genes may 
come into play that have not been considered so far. 
To  date,  two  tenascin  genes  are  known  in  chicken, 
namely TN-C and TN-R. The result of a low stringency hy- 
bridization of chicken genomic DNA with probes derived 
from either the human TN-X or chicken TN-C EGF-like 
region  pointed  to  the  existence  of further  tenascin-like 
genes in chicken  (Baumgartner and  Chiquet-Ehrismann, 
1993;  Chiquet-Ehrismann  et  al.,  1994).  This  report  pre- 
sents the characterization of a new member of the tenascin 
family in chicken that we termed TN-Y. We describe the 
cloning of cDNAs comprising the complete TN-Y coding 
region and the purification of the  encoded protein from 
chicken  heart  extracts  and  primary  cell  culture  condi- 
tioned media. Furthermore, we investigated the distribu- 
tion of TN-Y mRNA and protein in situ and present evi- 
dence for muscle fibroblasts as a source of TN-Y. 
Materials and Methods 
Isolation of TN- Y cDNA Clones from Chicken Heart 
cDNA Libraries 
Clone pcx (see Fig. 1 A) was amplified from chicken genomic DNA using 
two sets of nested primers. The first primer-set (set 1: 5' GGCACNG- 
CAGGNGACTCCATG 3' and 5' GGTCTCAGYTTCATYTC 3') corre- 
sponds to nt 6013-6033 and nt 6238-6254.  Subsequent internal amplifica- 
tions  were  performed  with  the  human TN-X  derived  primer-set  2  (5' 
GAGGGGCCTGGTGG 3' and 5' TFCATITCCGTGAAGGG 3'), corre- 
sponding to nt 6113-6126 and nt 6229-6245. The cDNA clones depicted in 
Fig. 1 A are derived from two cDNA libraries (except ptny3) by two dif- 
ferent strategies: cy cDNA clones were  obtained  by screening a  hgt11 
adult heart cDNA library  (Clonetech, Palo Alto, CA), and pcz cDNA 
clones are  PCR products from a  hZAP cDNA library of E18  chicken 
heart, constructed with the hZAP-cDNA synthesis kit  (Stratagene,  La 
Jolla, CA) according to the manufacturer's protocol. 
One screening procedure included 106 hgtl 1 phages, plated at a density 
of 2  ×  105 pfu/plate (24 ×  24 cm). Duplicate lifts onto Hybond N or N + 
nylon membranes (Amersham Intl.,  Amersham, UK) were  treated  ac- 
cording to  standard  procedures  and  UV cross-linked. All  membranes 
were hybridized to random-labeled digoxigenin (DIG)-dUTP TN-Y de- 
rived  cDNA-probes  according  to  the  manufacturer's protocol  (Boeh- 
ringer Mannheim Biochemica, Mannheim, Germany), using probes at a fi- 
nal  concentration  of  10-15  ng/ml.  Detection  of  positive  plaques  was 
carried out following the DIG luminescence detection kit protocol (Boeh- 
ringer  Mannheim  Biochemica,  Mannheim, Germany).  Positive  clones 
were picked and purified by one or two additional rounds of screening. 
For reprobing, filters were stripped 2  ×  20 rain in 0.2 M  NaOH, 0.1% 
SDS at 37°C, followed by a short wash in 2× SSC and stored at 4°C. The 
cDNA fragments were cut out with EcoRl from large scale phage DNA 
preparations and subcloned into pBluescript KS vectors (Stratagene, La 
Jolta, CA). 
Screening with pcx resulted in the isolation of cyl and cy3. To select for 
cDNA clones that provide further 5' sequence information, the same fil- 
ters were  hybridized to  DIG-labeled  cy3. From the  tl  positive cDNA 
clones (cy4 to cyl4) which were obtained, o]5 and ey6 were completely se- 
quenced, the others were characterized by partial sequencing and restric- 
tion mapping. The 5' and the 3' terminal sequences of all clones isolated 
exclusively encoded for  FNIII  domains which were either  identical  or 
highly homologous to each other even within one cDNA. Further screen- 
ing of either the kgtll adult heart or the hZAP embryonic day 18 heart 
cDNA library with  probe  cy6 resulted  in  the isolation of this type  of 
cDNA clones. These findings indicate  that identical  and highly similar 
FNIII  domains occur several times in different orders within the TN-Y 
transcript and render cDNA alignment difficult. Furthermore, they impli- 
cate a complex pattern of differential splicing of the TN-Y transcripts. 
To obtain more cDNA clones without the use of hybridization with the 
repetitive  sequences, PCR  amplification  on  4-8  ×  t04  phages  of the 
hZAP-cDNA library per 50-~zl reaction was performed with Taq-poly- 
merase (Boehringer Mannheim Biochemica, Mannheim, Germany) using 
nested gene-specific primers in combination with nested pBtuescript SK 
vector primers. The gene-specific primers were  designed for sequences 
unique for the FNIII domain YD2 as it appeared to be less abundant in 
the  TN-Y  transcript than the  YE-type  domains. Two different  cDNA 
clones pczla and pczlb (Fig.  1 A) were amplified by this approach and 
provided new 5' sequence information. The two clones cy66 and cyl02 
could be isolated from the hgtll adult heart cDNA library in two succes- 
sive screenings, using a probe that encompassed the 28--amino acid exten- 
sion and the half FNIII domain lead to the isolation of cy66 which was 
then used as a probe to isolate cy 102 (see Fig. 1 A). 
RNA Isolation, Reverse TranscriptionlPolymerase 
Chain Reaction (RTIPCR) 
Various tissues of adatt and embryonic day 4, 8, 11, and 18 chicken were 
dissected, quickly frozen, and then powdered  in liquid  nitrogen.  Total 
RNA was prepared  as described (Chomczynski and  Sacchi,  1987)  and 
used for  poty(A) +  RNA  preparation  with  the mRNA purification  kit 
(Pharmacia, Uppsala, Sweden) according to the manufacturer's protocol. 
First strand cDNA of poly(A) ÷ RNA was synthesized by AMV reverse 
transcriptase (Boehringer Mannheim) with oligo d(T)12-ta primers (United 
States Biochemical, Cleveland, OH) or random hexamer primers. Gene 
specific primers P1  and P3 (Fig. 2 A) with an EcoRI and Sail restriction 
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script KS vectors (Stratagene, La Jolla, CA) were used to amplify the 4.4- 
kb eDNA pray3 from E18 chicken heart eDNA with the Expand Long 
Template PCR System (Boehringer Mannheim). 
Construction  of Deletion Clones and DNA Sequencing 
Nested deletions of cy5, cy6, cy66, cy102, and ptny3 were prepared with 
the Nested Deletion Kit (Pharmacia, Uppsala, Sweden) as proposed by 
the manufacturer. Mini DNA-preparations of the nested deletion clones 
were linearized with appropriate restriction enzymes and sorted on 0.8% 
agarose gels according to their sizes. This was absolutely essential to ob- 
tain a  correct order of the tandemly repeated FNIII domains which are 
highly or completely identical. Sequences were obtained using Sequenase 
Version 2.0 (United States Biochemical). 
Northern Blot Analysis and In Situ Hybridization 
Electrophoresis of 10 I~g of total RNA (see RNA-isolation) per lane in 
formaldehyde containing gels was performed as described (Sambrook et al., 
1989),  followed by overnight transfer onto nylon membranes (positively 
charged; Boehringer Mannheim). The blot was stained in 0.5 M  Na-ace- 
tate (pH 5.2) containing 0.04%  methylene blue to visualize the 28S and 
18S rRNA. Membranes were hybridized using 50 ng/ml anti-sense ribo- 
probe of cy5 and hybridizing bands were detected using the DIG-lumines- 
cent detection kit (Boehringer Mannheim). In situ hybridization was done 
on freshly prepared cryosections (15 ~m) of different chicken embryonic 
tissues as described by Koch et al. (1995). DIG-labeled  anti-sense ribo- 
probes were in vitro transcribed from the TN-Y-derived cDNA clone cy5, 
from the TN-C derived eDNA clone cTn8 (see Spring et al., 1989)  and 
from a eDNA clone derived from chicken laminin ~/I, which was kindly 
provided by Dr. Roberto Perris (manuscript in preparation). 
Isolation,  Purification,  and Electron Microscopy of 
TN- Y Protein Variants 
Commercially available frozen hearts from adult chicken were dissected 
from fat but not from the major vessels, homogenized at 4°C with a Poly- 
tron homogenizer in 20 mM Tris (pH 7.5) washing buffer, containing pro- 
tease inhibitors PMSF (1 mM) and NEM (2.5 mM) (Fluka, Buchs, Swit- 
zerland), and centrifuged for 30 rain at 19,700  g. This washing step was 
repeated once, followed by homogenization of the pellet in 5-10 times the 
volume of extraction buffer (pH 8.0) that contained 25 mM "Iris, 400 mM 
NaCl, and 10 mM EDTA and protease inhibitors as described above. Ex- 
traction proceeded  overnight at 4°C, the suspension was centrifuged at 
23,500 g and the supernatant was passed through a filter and concentrated 
by 45%  ammonium sulfate precipitation  at 4°C. The residual pellet was 
treated with 2% deoxycholate (DOC), 2 mM EDTA in washing buffer for 
1 h at 4°C, and aliquots of supernatants and pellets from each step were 
tested by Western blotting using anti-TN-Y antibody (not shown). The 
major part  of TN-Y  polypeptides from either  heart  extracts or  condi- 
tioned media of cell cultures was detected in the 45% ammonium sulfate 
precipitate  and was dialyzed against lx  TBS. Subsequently, the sample 
was passed over a  gelatine agarose column (Sigma, Buchs, Switzerland) 
and the flow through was applied immediately to an anti-TN-Y affinity 
column. The  column was  washed  extensively with  TBS/0.01%  Tween 
(wash 1), followed by a wash step with the same buffer including 1% Tri- 
ton X-100 (wash 2). The TN-Y protein was eluted with 8 M LiCI, pH 11.0, 
at  4°C.  Fractions  were  immediately  neutralized,  dialyzed  in  l x  TBS, 
0.01%  Tween  at  4°C, and shock frozen in liquid  nitrogen. Samples for 
electron microscopy were prepared  and analyzed as described in Koch 
et al. (1992). 
SDS-PA  GE and Immunoblotting 
Affinity-purified TN-Y or samples of conditioned media were separated 
by 6 or 3-15% gradient SDS-PAGE under reducing or non-reducing con- 
ditions. Protein bands were either stained with Coomassie Blue or elec- 
troblotted  (MilliblotTM;  Millipore  Corp., Bedford, MA) to Immobilon-P 
membranes (Millipore) which were incubated with affinity-purified anti- 
TN-Y antibody, diluted 1:2,000, and detected with horseradish peroxidase 
conjugated secondary antibody (Cappel,  Durham, NC), diluted  1:2,000, 
followed by ECL-detection (Amersham Intl.). 
Heparin Binding Assay 
Fractions of affinity-purified, dialyzed TN-Y were passed over a heparin 
agarose (Sigma) column followed by extensive washes with 1× TBS (20 
mM Tris, pH 7.4, 150 mM NaCl), 0.01% Tween and eluted with 1 M NaCl 
in 1  x  TBS, 0.01% Tween. Loaded material, flow through, washes and 
eluted fractions were analyzed by SDS-PAGE and immunoblotting. 
Staining of Cryosections 
Air-dried and fixed (4% paraformaldehyde) cryosections were blocked in 
1x  TBS/0.3%  BSA, incubated first with anti-TN-Y antibody and then 
with  the  appropriate  rhodamine-labeled  secondary  antibody  (Cappel, 
Durham, NC) with intermediate washes. Sections were overlaid with 90% 
glycerol in PBS and covered with coverslips. In some cases, adjacent sec- 
tions were stained by hematoxylin and eosin to reveal the tissue architecture. 
Tissue Cultures 
Hind  limb muscles from  10--12-d-old  chicken embryos were  dissected, 
trypsinized with a 1:10 dilution of trypsin (0.25% stock, GIBCO BRL) in 
PBS for 3  x  15 rain at 37°C, and collected in medium containing 10% 
horse serum (HS)  or  FCS.  After  centrifugation, the  pellet  was  resus- 
pended in an appropriate  volume of serum-free minimum essential me- 
dium (MEM; GIBCO BRL) containing 4% chicken embryo extract (pre- 
pared from 11-d-old chicken embryos with an equal volume of 0.11% (wt/ 
vol) glucose in PBS). Cells were either plated directly in the presence of 
10%  HS (GIBCO  BRL) or 10%  FCS  (GIBCO  BRL) on tissue culture 
dishes coated with 0.3 ~g/ml gelatine (Bio-Rad) to obtain a myoblast/mus- 
cle fibroblast co-culture, or they were preplated on non-coated plastic tis- 
sue culture dishes for 1 h at 37°C to separate adhering muscle fibroblasts 
from non-adhering myoblasts. The myoblast-enriched supernatant was ei- 
ther discarded or plated on gelatine-coated tissue culture dishes. Adher- 
ing muscle fibroblasts were slightly trypsinized in a 1:10 dilution of trypsin, 
pelleted  by  centrifugation  and  resuspended  in  MEM  containing  4% 
chicken  embryo extract  with  either  10%  HS  or  10%  FCS.  Cells were 
plated at a  density of about 6  x  104/ml in 24-well plastic tissue culture 
dishes and aliquots of conditioned media were collected at different time 
intervals. 
Results 
Structural Similarities and Differences in the Primary 
Structure of TN- Y Compared to the Other Tenascins 
Since the fibrinogen globe is the most conserved part of 
the known tenascins, we designed nested primers specific 
for the human TN-X fibrinogen part to perform PCR reac- 
tions on chicken genomic DNA.  A  genomic fragment of 
460 bp (pcx, Fig. 1 A) was amplified that contains 130-bp 
coding sequence interrupted by an intron of 330 bp. Subse- 
quent screening strategies (as explained in Materials and 
Methods) led to the identification of the eDNA clones de- 
picted in Fig. 1 A. The complete sequence, coding for one 
splice variant of TN-Y was deduced from cy102, cy66, cyl, 
and ptny3. Clone ptny3 represents a subcloned RT-PCR- 
amplification  product.  It  was  the  smaller  of two  major 
PCR fragments of 7.5 and 4.4 kb which were amplified, us- 
ing the primers P1 and P3 (Fig. 1 B). Two major bands of 
the appropriate relative sizes 8.0 and 4.9 kb were also ob- 
tained with the primer set P4 and P3 (Fig. 1 B). This im- 
plies the existence of at least two major splice variants of 
TN-Y. We identified and sequenced two sets of cDNA- 
clones that arose by alternative splicing at least at two dif- 
ferent sites of the TN-Y transcript (Fig. 1 A). Sequencing 
of sequential nested deletion clones of cy102, cy66, ptny3, 
and cyl revealed an open reading frame of 5,827 bp encod- 
ing the smallest TN-Y-variant. The cDNA clones cy102 and 
cyl  comprise  5'  and  3'  untranslated  sequences,  respec- 
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mRNA. The predicted primary sequence of 1,914  amino 
acids for this variant and a structural model is presented in 
Fig. 2. The putative signal peptide cleavage site was deter- 
mined according to the  -1,  -3 rule given by von Heijne 
(1986).  The  NH2-terminal  sequences,  that  contribute  to 
the central globe of TN-C (Spring et al.,  1989)  and which 
are also present  in TN-R (N6renberg et al.,  1992;  Fuss 
et al.,  1993)  and TN-X (Bristow et al.,  1993),  are mostly 
absent from TN-Y. The NH  2 terminus of TN-Y is defined 
by a small proline-rich peptide (residue 20 to 36) which is 
followed by three and a half heptad repeats (residues 37 to 
61).  Heptad  repeats  form et-helical  coiled-coil structures 
(Parry, 1982) which are thought to be responsible for the 
trimerization  of  TN-C  (Spring  et  al.,  1989)  and  TN-R 
(N6renberg et al., 1992; Pesheva et al., 1989). In all tenas- 
cin  molecules,  this  region  is  surrounded  by  a  different 
number of cysteine residues  that could contribute to the 
stabilization of multimeric structures.  In TN-Y, four cys- 
teines are found in this region compared to 7-10 cysteines 
in the other tenascins. Thus TN-Y monomers could also 
associate into oligomeric structures which may be of lower 
order than those described for TN-C (Erickson and Igle- 
sias,  1984)  and TN-R (Pesheva et al.,  1989; N6renberg et 
al., 1992). 
Residues 90-134  represent one and a half EGF-like re- 
peats where the intact repeat complies with the conserved 
cysteine spacing pattern X4CX3CX5CXaCXICX8C  , typical 
for the tenascins (Spring et al., 1989). The final 1/2 EGF-like 
repeat  (residue  135-148)  appears to be  degenerated  and 
only the cysteines 1 and 3 are retained. 
The EGF-like region is followed by one FNIII domain 
(YA; residues 151-239),  which is separated from the other 
FNIII domains by a novel sequence. This section contains 
a  serine/proline  (SP)-rich  motif  with  the  consensus  se- 
quence SPX (whereby X can be any amino acid) which is 
repeated  23  times  within  98  amino  acids  (residues  260- 
352),  followed by 99 amino acids that show no particular 
homology to any known sequence motif. This "SPX-con- 
taining domain" is unique to TN-Y and has not been re- 
ported  to  appear  in  other  tenascins.  Interestingly,  it  is 
joined to the second half of a FNIII domain (residues 452- 
512).  To check the exon-intron organization of the TN-Y 
gene in  the  novel 5' region, we analyzed genomic DNA 
and genomic clones (not shown). Exon primers were used 
to sequence the exon-intron boundaries which are pointed 
out  in  Figs.  1 and  2.  Our  results  confirmed the  correct 
splicing of the described cDNA clones covering the 5' re- 
gion of TN-Y. Interestingly, the SPX-domain and the half 
FNIII domain are encoded within a  single exon which is 
Figure 1.  Alignment and PCR-amplification  of TN-Y cDNA clones. (A) cy-clones were isolated by screening an adult heart cDNA library; 
p-clones were PCR amplified from either chicken genomic DNA (pcx), from El8 chicken heart cDNA library (pczla and pczlb) or by 
RT-PCR from El8 chicken heart mRNA (ptny3). The scale bar at the top indicates the length of the cDNA clones in kilobases (kb). 
Clones cy]02, cy66, ptny3 and cyl comprise the full-length sequence of the smallest TN-Y variant. Two sets of clones deriving from al- 
ternative splicing at two sites are indicated (pczlb/pczla and cy3/cy5/cy6).  The different repetitive Y-type FNIII domains are defined by 
a distinct shading; other domains are shown as open boxes. Bars mark the 5' and 3' untranslated regions. EGF, EGF-like repeats; SPX, 
SPX-containing domain; 1/2, half FNIII domain; 8, FNIII domain 8; FG, fibrinogen globe; YA-YE, TN-Y-type FNIII domains (subtypes 
numbered). YE3* lacks the first codon but is otherwise identical to YE3. Filled arrowheads mark intron positions identified in genomic 
clones and arrows indicate the binding sites of primers P1, 3, 4 used for RT-PCR amplification from El8 chicken heart mRNA (B): lane 
1, cDNA fragments amplified by primer-set P1/P3. The 4.4-kb fragment corresponds to ptny3; lane 2, cDNA fragments amplified by 
primer-set P4/P3. 
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ture. The numbering of the residues is given on the right, FNIII domains are designated on the left. Intron-insertion  sites (arrowheads) 
and putative N-glycosylation  sites (underlined) are indicated. The signal peptide (1-19) is followed by a short proline-rich peptide (20- 
36) and 3 1/2 heptad repeats (37-61). A short cysteine-rich sequence (62-89) leads to the EGF-like region (90-150). The FNIII domain 
YA (151-239) precedes the SPX-containing  domain (240-451) that contains 23 perfect S-P-X motifs (shaded boxes) and is together with 
the half FNIII domain contained in one exon. The following 11 FNIII domains YB1-YE5 (513-1614) are defined as repetitive Y-type 
FNIII domains, referring to their 70-100% sequence identity. FNIII domain 8 (1615-1696) corresponds to the equivalent  FNIII domain in 
TN-C, TN-R, and TN-X; the four residues highlighted in bold (W, L, Y, T) are conserved in every FNIII domain. A short proline-rich pep- 
tide (1697-1704) leads to the COOH-terminal fibrinogen  globe (1705-1914). (B) The TN-Y polypeptide is arranged as a structural model 
using different symbols for the various domains as proposed by Spring et al. (1989). A small ellipse indicates the NH2 terminus, the wavy 
line stands for the heptad repeats, and the half circle to follow indicates a cysteine-rich region that precedes the complete and two half- 
EGF-like repeats which are shown as black diamonds. FNIII domains are drawn as boxes; distinct shading patterns for the repetitive 
FNIII domains were used to label the different types YB, YC, YD, YE. The SPX-containing  domain, unique to TN-Y, that interrupts 
the FNIII domain series is shown as a rhomb, bisected by a dotted line that demarcates the part with repeated S-P-X-motifs  from the 
second part which is joined to the half FNIII domain. A short dash connects the COOH-terminal fibrinogen  globe, drawn as a black cir- 
cle. The potential N-glycosylation sites are shown as thin vertical lines and intron insertion sites at the 5' end are indicated as black ar- 
rowheads above the model. The sequence data are available from GenBank/EMBL/DDBJ under accession number X99062. 
separated from the flanking FNIII domains by two introns. 
Further introns were found to separate the FNIII domain 
YA  from  the  EGF-like repeats  and the  latter  from  the 
NHz-terminal part including the heptad repeats. All splice 
junctions examined in the 5'  region revealed phase  1 in- 
trons that split the codon after the first position (Patthy, 
1991). 
The following 11 FNIII domains are 70-100% identical 
in  terms  of  their  nucleotide  sequence  and  cannot  be 
aligned in a  collinear fashion with either TN-X, -C or -R 
(nor can FNIII domain YA). Therefore, we named them 
with a  capital letter designating the  type of domain fol- 
lowed by numbers for the varying subtypes. The preceding 
Y  identifies them as FNIII domains of TN-Y to prevent 
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to as repetitive FNIII domains and can be classified into 
four types of FNIII domains, YB, YC, YD, and YE. This 
classification was based on NH2-terminal differences within 
the otherwise highly similar FNIII domains (see Fig. 2 A). 
The YB domains differ from all other FNIII domains by 
an  NH2-terminal 28  amino acid extension. Five YE sub- 
types  (YE1-YE5)  and  two  YD  subtypes  (YD1,  YD2) 
could be identified within the ptny3 cDNA (Figs.  1 A and 
2 B). YE1-YE5 occur singly, in a  doublet or in a  triplet, 
and are separated by either a YD2 or YD1 domain. Only 
single YB- and YC-type domains are represented in ptny3, 
indicating that they may occur less frequently than YE and 
YD domains. The same types of domains such as YB2 and 
YB3  or  YE3  and  YE4  are  88  to  99%  identical  on  the 
amino acid and on the nucleotide level. Interestingly, the 
subtypes YD1 and YE2 occur twice as identical domains 
within  clone  ptny3.  Only a  single  subtype  of each,  YB 
(YB1) and YC (YC1) were contained in this clone. Two 
more YB and one more YC subtypes were  identified in 
the cDNA clones pczla and pczlb, which were generated 
by an alternative splicing event 3' of the half FNIII domain. 
A second set of cDNA clones, cy3, cy5, and cy6 were gen- 
erated by differential splicing after domain YE5 (Fig. 1 A). 
They contain the subtypes YD2, YE1, and YE3 that come 
as  tandemly repeated  triplet.  FNIII domain YE3*  lacks 
the  first  three  nucleotides  but  is  otherwise  identical  to 
YE3. If this difference genuinely reflects the organization 
of the TN-Y gene, cy6 might lie further 5' of the position 
shown in Fig. 1 A. These findings make clear, that identical 
and  highly similar FNIII domains occur several times  in 
different orders within the TN-Y transcript. Furthermore, 
they implicate a complex pattern of differential splicing of 
the TN-Y gene-products. The FNIII domain that follows 
the series of repetitive Y-type FNIII domains in ptny3 is 
most homologous to the corresponding one in all other te- 
nascins and therefore is referred to as FNIII domain 8, ac- 
cording to the tenascin nomenclature proposed in several 
publications (Aukhil et al., 1993; Bristow et al., 1993; Chi- 
quet-Ehrismann, 1993).  Domains YD2, YE1, and YE3 of 
ptny3 differ in one single nucleotide each from their coun- 
terparts in cy6 and cy5. We cannot exclude that such mini- 
mal sequence variations are due to PCR errors. FNIII do- 
mains with only one amino acid difference such as YE3 
and YE4 show a number of additional differences within 
their DNA-sequence as well and are therefore considered 
as divergent domains. 
Comparison of the COOH-terminal fibrinogen part and 
the  FNIII domain 8 of TN-Y to the  same region in  the 
other tenascins revealed only 59% identity to human and 
mouse  TN-X  compared  to  over  80%  identity  between 
chicken, human, and mouse TN-C in this region (Fig. 3). 
This together with the different domain organization indi- 
cates that we did not isolate the chicken TN-X, but a new 
member of the tenascin family that we termed TN-Y (Chi- 
quet-Ehrismann et al., 1994, 1995). 
Expression  of TN-  Y in Developing and Adult Chicken 
The  expression  of TN-Y transcripts  was investigated  by 
Northern blot analysis (Fig.  4)  using cy5 anti-sense ribo- 
probes  (see  Fig.  1 A).  Two major TN-Y mRNA bands, 
roughly estimated to be 6.5 and 9.5 kb long, were detected 
on Northern blots of total RNA from tissues of different 
embryonic stages and adult chicken (Fig.  4). This result is 
in agreement with the  amplification of two major TN-Y 
cDNA fragments in  the  RT-PCR shown in  Fig.  1 B.  A 
lower molecular mass band of ~5  kb appears  after long 
blot exposure (Fig. 4, left panel) and is also visible in adult 
ovaries and lung. We cannot exclude that this band repre- 
sents yet another splice variant of TN-Y which is differen- 
tially  expressed  during  development  and  in  the  adult. 
However, we tend  to consider the  5-kb band as  a  back- 
ground signal since it is not reproducibly detected. 
The 6.5- and the 9.5-kb TN-Y transcripts could not yet 
be detected in 4-d-old chicken embryos but were found to 
be most abundant in skeletal muscle and heart from later 
embryonic stages as presented in the developmental pro- 
file, as well as in adult tissues (Fig. 4). The 4-d-old embryos 
were  dissected into trunk and head  and  the  8-d-old em- 
bryos into trunk, heart and head. RNA from the trunk was 
included in the developmental Northern blot. The RNAs 
Figure  3.  A  comparison  of 
the tenascins in chicken and 
mammals,  and  their  struc- 
tural  relationship.  The  den- 
drogram  was created  by the 
multiple  alignment  program 
"pileup" based on the amino 
acid sequence of the fibrino- 
gen  globe  and  the  adjacent 
FNIII domain  8  (according 
to Chiquet-Ehrismann  et al., 
1994). Numbers  in  the  den- 
drogram  indicate  sequence 
identities  in  %.  TN-Y  and 
TN-X are as similar (59%) as are TN-C and TN-R (58%). On the left, only the smallest variant of each tenascin is shown. Symbols used 
for TN-Y are explained in Fig. 2. Differences at the NH2 termini of the tenascins are indicated by black ellipses and pie segments; wavy 
lines represent heptads which are followed by EGF-like repeats shown as black diamonds (chicken and mammalian TN-C differ in one 
EGF-like repeat as indicated by a white diamond). Constant FNIII domains 1-8 in TN-C and TN-R and the equivalent domains in TN-X 
(6-8), and in TN-Y (8) are shown as white boxes. The 25 X-type FNIII domains are indicated by a large dotted box (not to scale). Black 
circles represent the NHz-terminal fibrinogen globes in all tenascins. 
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muscle  and adult tissues.  Northern blots of equal amounts (10 
txg) of total RNA or poly(A)  + RNA from various tissues of em- 
bryonic day 4, 8, 11, 18 and adult chicken were hybridized  with 
digoxigenin-labeled  anti-sense  cy5 riboprobe. Two major TN-Y 
transcripts  of ~,6.5 and 9.5 kb (arrows) are detected in various 
samples,  a potential third transcript  of 5 kb can be detected in 
some tissues (E4 t; E8 h/t; Ell h*; adult o/1). t, trunk; h, heart (h* 
and h of Ell means same sample, different exposure times); m, 
skeletal muscle; g, gizzard; o, ovaries; l, lung. (Left panel) Exposed 
for  1 h;  (middle and  right panels) exposed for  10 min.  RNA 
marker sizes are given in kb. At the bottom, ribosomal 28S RNA 
from each sample shows that comparable amounts of RNA were 
loaded. 
from the heads were tested separately and turned out not 
to contain TN-Y mRNA. Weak TN-Y mRNA expression 
could be detected in gizzard and skin of lt-d- and in brain 
of 18-d-old  embryos, respectively, but  not  in  liver from 
these stages (not shown). In the adult, TN-Y continued to 
be expressed in  heart  and muscle and was also found in 
gizzard, ovaries and lung (Fig. 4, right). 
The 6.5- and 9.5-kb TN-Y mRNA variants are differen- 
tially expressed during development. Both transcripts can 
first be detected in the trunk (but not in the heart) of 8-d- 
old and in heart of 11-d-old chicken embryos after long ex- 
posure of the blot (Fig. 4, left) and gradually increase with 
the age of the embryo. Both variants are equally abundant 
in embryonic and adult heart whereas the 6.5-kb transcript 
dominates in skeletal muscle. During embryogenesis, TN-Y 
mRNA  expression  is  higher  in  skeletal  muscle  than  in 
heart but the inverse pattern is found in the adult, where 
expression in skeletal muscle is reduced (Fig. 4, right). 
Purification and Electron Microscopy of TN- Y Protein 
To get information about the  structure  and the distribu- 
tion of the TN-Y protein, we prepared a polyclonal antise- 
rum directed against glutathione S-transferase- and 13-galac- 
tosidase-fusion proteins with cy6 and  cy3 (see  Fig.  1 A) 
which  were  expressed  in  bacteria.  Columns  of  affinity- 
purified  anti-TN-Y  antibody were  used  to  isolate TN-Y 
protein  from  adult  chicken  heart  and  from conditioned 
media of embryonic muscle primary cultures grown in me- 
dium  containing  10%  horse serum  and  4%  chicken em- 
bryo  extract  (for  details  see  below).  TN-Y  from  adult 
heart  was predominantly found  in  the  supernatant  after 
high salt/EDTA extraction,  but  not  in  the  DOC-treated 
fraction when analyzed by SDS-PAGE. It is also released 
into the  culture medium by muscle fibroblasts under the 
above mentioned culture conditions.  Thus TN-Y is a  se- 
creted molecule. 
lmmunoaffinity-purified chicken TN-Y separated by SDS- 
PAGE under reducing conditions appears as three major 
bands,  with  a  high molecular mass doublet  and  a  lower 
molecular weight band (Fig. 5).  The  apparent molecular 
mass of the heart-derived TN-Y is N400 kD for the double 
band, and 300 kD for the lower band, respectively (Fig. 5, 
A and B). TN-Y isolated from cell culture conditioned me- 
dium is of markedly lower size, namely 220 kD (for the 
double band) and 170 kD (Fig. 5 C). All six variants were 
recognized by the polyclonal anti TN-¥ antibody on im- 
munoblots (Fig. 5, B and C). 
Immunoaffinity-purified TN-Y  from  heart  was  exam- 
ined  by rotary shadowing  electron microscopy. Electron 
micrographs  revealed  monomeric TN-Y  molecules,  ap- 
pearing  as  rod-like  structures  with  two  terminal  knobs 
(Fig. 6). The length of the TN-Y arms ranged from 70 to 
125  nm. An accumulation of short molecules (70-75 nm) 
and  intermediate  sized  molecules  (95-100  rim)  was  ob- 
served but larger TN-Y arms of ~120 nm were found as 
well. The micrographs suggest that TN-¥ from the heart 
does not form disulfide-linked multimers, although it can- 
not be excluded that oligomers were dissociated during ex- 
traction  and  purification.  Except  for  the  difference  in 
length,  the  molecules resemble monomeric TN-C mole- 
cules as they were isolated from chicken gizzard (Chiquet 
et al., 1991). 
Tissue Distribution of the TN- Y Protein and mRNA 
We investigated the distribution of TN-Y in breast muscle 
and heart of 18-d-old chicken embryos and adult chicken. 
Consecutive  sections  were  stained  with  anti-TN-Y  and 
anti-TN-C antibody, respectively (Fig. 7, A  and  B).  The 
TN-Y protein  was  found  to  be  distributed  in  a  fibrillar 
manner mainly between bundles of muscle fibers (in the 
perimysium) in embryonic and adult breast muscle (Fig. 
7 A); in the latter it was additionally found between single 
muscle fibers, in the endomysium (Fig. 8 D). To address 
the question of which cells express TN-Y, in situ hybridiza- 
tion was performed on adjacent sections of 18-d embry- 
onic breast muscle and compared to TN-C (Fig. 7, C and 
D) and laminin (Fig. 7 F) expression. The in situ hybridiza- 
tion revealed muscle fibroblasts which populate the peri- 
mysium to be the source of TN-Y mRNA (Fig. 7, C  and 
E).  In contrast,  fibroblasts  within  the  tendon  expressed 
TN-C mRNA (Fig. 7 D) while no TN-Y mRNA could be 
detected in these cells (Fig. 7 C). However, diffusion of the 
TN-Y protein into the tendon is observed (Fig. 7 A). Co- 
expression of TN-Y and TN-C was found in the connective 
tissue  surrounding  blood  vessels,  but  note  that  smooth 
muscle cells  around  arteries  express TN-C,  while  TN-Y 
protein and mRNA are absent (Fig. 7). Laminin and TN-Y 
expression in  embryonic breast muscle is compared at a 
higher  magnification,  clearly showing  TN-Y mRNA  re- 
stricted to the cells within the perimysium (Fig. 7 E), while 
laminin  mRNA  is  expressed by both  muscle fibroblasts 
and myofibers (Fig. 7 F). 
Hagios et al. Tenascin-Y  in Muscle  Connective  Tissue  1505 Figure 5.  Analysis of immunoaffinity-purified TN-Y from adult chicken heart and from cell culture conditioned media. Heart extracts 
(A and B) or conditioned media from cocultures of primary muscle fibroblasts and myoblasts (C) were loaded (L) on an anti-TN-Y an- 
tibody column. Flow through (F) and washes (Wl, W2) were collected and TN-Y fractions were eluted with 8 M LiCl, pH 11. Samples 
were analyzed by SDS-PAGE, performed under reducing conditions. (A) Coomassie blue-stained 6% SDS-polyacrylamide gel of TN-Y 
purified from heart, and (B) immunoblot of the same samples incubated with anti-TN-Y antibody. A ~400-kD doublet (arrowheads) 
and a ~300-kD variant (arrow) of TN-Y from heart were specifically eluted from the column (fractions 5-9) and detected by the anti- 
TN-Y antibody, but were not present in the flow through or wash fractions. (C) Immunoblot of TN-Y purified from primary muscle cell 
conditioned medium incubated with anti-TN-Y antibody. A ~220-kD doublet (arrowhead) and ~170-kD variant (arrow) were detected 
in eluted fractions (7-14). Protein marker sizes are given in kD. 
TN-Y is also absent from the aortic smooth muscle wall 
in embryonic heart but is abundant in the tunica adventi- 
tia,  a  layer of connective tissue that surrounds the vessel 
wall  and anchors it to the  surrounding tissue  (Fig.  8 B). 
The epicardium and the pericardium, two continuous con- 
nective tissue layers that delimit the myocardium and the 
pericardial cavity, respectively, stained positive for TN-Y 
in  embryonic  and  adult  heart.  Sporadic  TN-Y  staining 
within the myocardial connective tissue was observed as 
well  (Fig.  8, B  and  C).  In situ  hybridization of 18-d-old 
chicken heart  revealed  weak,  sporadic TN-Y expression 
within the muscle tissue and the epicardium (not shown), 
which  parallels  the  distribution  of the  TN-Y  protein  in 
adult heart (Fig. 8 C). 
TN-Y Has Heparin-binding Activity 
TN-C and TN-X have been shown to bind heparin under 
physiological salt conditions (Chiquet et al.,  1991; Matsu- 
moto et al., 1994). For TN-C, this ability was confined to a 
single  region within the fibrinogen-like domain (Fischer 
et al., 1995). To test whether TN-Y may also interact with 
heparin, we carried out binding experiments with purified 
TN-Y on heparin-agarose columns. Both TN-Y from heart 
(Fig.  9 A) and from conditioned medium (Fig.  9 B) were 
retained  on the  heparin column under physiological salt 
conditions and could be eluted with 1 M NaC1. This indi- 
cates that heparin-binding ability may be a  common fea- 
ture of tenascin-like proteins. 
TN- Y Production by Primary Muscle Fibroblasts 
Chicken embryo skin fibroblasts  (CEFs) cultured in me- 
dium containing 10%  fetal calf serum release TN-C into 
the culture media (Chiquet and Fambrough, 1984b). Based 
on the TN-Y expression pattern in breast muscle connec- 
tive tissue (see Fig. 7), we considered muscle fibroblasts to 
be a putative source for TN-Y purification. Cocultures of 
myoblasts  and  muscle  fibroblasts  released  the  220-  and 
170-kD  variant  of TN-Y  into  the  medium  if they  were 
grown in medium containing 10% HS and 4% chicken em- 
bryo extract, but not if they were kept in 10% FCS and 4% 
chicken embryo extract  as  is  demonstrated  by immuno- 
blots using the polyclonal anti-TN-Y antibody (Fig. 10 B). 
Under  non-reducing conditions  the  220-kD  polypeptide 
was absent  and  instead  oligomeric TN-Y barely entered 
the gel (Fig.  t0 C). It appears therefore that TN-Y in con- 
ditioned medium, in contrast to the protein extracted from 
adult heart tissue,  forms multimeric structures.  The  170- 
kD band persisted under non-reducing conditions, indicat- 
ing that it is probably not included in oligomers of TN-Y 
or that it represents a degradation product. To ascribe the 
TN-Y  production  to  either  myoblasts  or  muscle  fibro- 
blasts, the two cell types were separated and plated in 10% 
horse serum and 4%  chicken embryo extract. TN-Y pro- 
tein was detected in Western blots from conditioned me- 
dia of both cell types with a markedly higher production in 
the muscle fibroblast culture (not shown). Therefore fibro- 
blasts contaminating the myoblast/myotube-enriched cul- 
ture may be the source of TN-Y protein synthesis, but we 
cannot exclude the possibility that undifferentiated myo- 
blasts also express TN-Y. These results point to the exist- 
ence of a TN-Y inducing factor in horse serum that acts on 
fibroblasts. Such a factor may be considered as a differen- 
tiation-inducing activity, which regulates the production of 
a cell type-specific gene product of muscle fibroblasts. 
Discussion 
A Novel Tenascin Family Member 
with Unique Features 
This is the first report presenting cDNA and protein data 
on TN-Y,  the  third  tenascin-like  molecule  identified  in 
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heart. Monomeric TN-Y of three major sizes were identified  in 
rotary-shadowed  samples  of  TN-Y  purified  from  anti-TN-Y 
Sepharose columns:  (top) small sized TN-Y ('-~70 nm); (middle) 
intermediate-sized TN-Y (~100 nm); (bottom) large sized TN-Y 
(~120 nm), standard deviation,  20 nm. The molecules  appear as 
rod-like structures with two terminal knobs. Bar, 50 nm. 
chicken.  TN-Y is a  typical tenascin in  that it contains all 
the  domains  present  in  other known family members in 
the  same  arrangement,  namely heptad  repeats, followed 
by EGF-like repeats, FNIII domains and a domain homol- 
ogous  to  fibrinogen.  However, TN-Y is  unique  with  re- 
spect to its NH2 terminus, to the insertion of a new domain 
which is rich in serines and prolines and to its series of al- 
most identical FNIII domains. 
The 3.5 heptad repeats of TN-Y provide the basis to as- 
semble at least three TN-Y monomers analogous to TN-C 
and TN-R trimers (Pesheva et al., 1989; Spring et al., 1989; 
N6renberg et al.,  1992).  However, from heart muscle ex- 
tracts, only monomeric TN-Y molecules could be purified 
over the  anti-TN-Y antibody column, while in muscle fi- 
broblast conditioned  culture  medium TN-Y seems to be 
present in an oligomeric form. A  similar situation has been 
reported for TN-C, which typically is a hexamer when iso- 
lated from cell culture, but can be extracted only in its mono- 
meric  form  from  adult  chicken  gizzard  (Chiquet  et  al., 
1991). The NH2 terminus of TN-Y is short and comprises 
only 4 cysteines compared to 8 and 7 in TN-C and TN-X, 
respectively. Disulfide bridges between the most NH2-ter- 
minal cysteines of two mature TN-C trimers are thought to 
connect two trimers to assemble the final six-armed struc- 
ture of TN-C (Spring et al., 1989; Chiquet et al., 1991). The 
corresponding cysteine residue is present neither in TN-X 
nor  in  TN-Y. Thus,  only dimers  and  trimers  have  been 
predicted for TN-X (Bristow et al., 1993)  and may also be 
the prevalent form of TN-Y. 
The  EGF-like region of TN-Y is  encoded  by a  single 
exon as in its TN-C (Gulcher et al., 1991)  and TN-X (Bris- 
tow et al., 1993) counterparts but it is the shortest such re- 
gion in all tenascins, consisting of one complete EGF-like 
repeat flanked by two half-EGF-like repeats. Characteris- 
tic for a EGF-like repeat are six conserved cysteines where 
cysteine residues  1-3,  2-4,  and  5-6 form disulfide  bridges 
(Cooke  et al.,  1987;  Chiquet-Ehrismann,  1990).  The  cys- 
teines 1 and 3 are still present in the second half EGF-like 
repeat of TN-Y while cysteine 2 is lost, possibly due to the 
lack of its partner cysteine 4. 
The ability to bind heparin may be common to all tena- 
scins and the necessary active site in TN-C has been shown 
to  reside  within  the  second  half of the  fibrinogen  globe 
(Fischer et al., 1995).  In fibronectin six discontinuous basic 
residues within the FNIII domain 13 are brought together 
on one side of the protein to form a  heparin-binding site 
(Busby et al., 1995).  The fibrinogen domain of all known 
tenascins contains a  high number of conserved basic resi- 
dues  which  might  provide  an  active  surface  for heparin 
binding. 
The most intriguing feature about the TN-Y structure is 
the occurrence of a  new domain rich in serines and pro- 
lines, which are repeated in the consensus pattern  S-P-X 
over a stretch of ~100 residues. This SPX-rich domain in- 
terrupts the  series of FNIII domains after FNIII domain 
YA and is, together with a half FNIII domain, encoded by 
a single exon. Database searches revealed no homology of 
the SPX-domain to any known protein. However, a num- 
ber  of  structurally  and  functionally  unrelated  proteins 
such as neurofilaments (Zopf et al., 1990),  ankyrin (Otto 
et al.,  1991),  RNA-polymerases (Bird and Riddle,  1989), 
and bacterial proteins (Jerlstr6m et al., 1991) were found 
to have other well conserved serine/proline  spacing pat- 
terns within repetitive motifs. The function of these motifs 
within  these  proteins  has  not  been  elucidated  in  most 
cases, but it seems likely that serine residues of intracellu- 
lar proteins can be subject to phosphorylation as proposed 
for the neurofilaments (for review see Steinert and Roop, 
1988).  Serine  residues  in  extracellular  proteins can have 
carbohydrates attached to the OH-group as in mucins or 
proteoglycans. The role of repeating proline residues may 
be  to  closely  pack  regional  modifications  or  structural 
units  by  inducing  regular  13-turn conformations.  In  col- 
lagens, proline and hydroxyproline help to form and stabi- 
lize the triple-stranded helix. Whether the SPX-domain of 
TN-Y  is  posttranslationally  modified  and  represents  a 
structural  unit  remains to  be  elucidated.  It could  be  re- 
quired to form a  complete domain with the adjacent half 
FNIII domain that may otherwise not be able to fold prop- 
erly. To our knowledge, this is the first report of the occur- 
rence  of a  half FNIII domain  within  a  protein.  A  more 
tempting explanation would be, that the SPX-domain con- 
fers  novel  structural  and  functional  features  to  TN-Y 
which are not shared by other tenascins. 
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in fetal and adult heart and in 
adult  skeletal  muscle.  Sec- 
tions of heart from an 18-d- 
old  embryo  (A  and  B)  or 
from adult chicken (C), and 
of adult skeletal  muscle (D) 
were stained with hematoxy- 
lin and eosin (A) or anti-TN-Y 
antibody  (B-D).  In  heart, 
TN-Y  is  prominent  in  the 
epicardium  (B  and  C)  that 
delimits  the  heart  muscle 
(myocardium), as well  as in 
the  pericardium  and  in  the 
tunica  adventitia  around 
smooth  muscle  walls  (B). 
TN-Y  staining  between  the 
cardiac  muscle  cells  of  the 
myocardium  was  observed 
in adult heart (C). (D) TN-Y 
staining  in  the  endomysium 
and the perimysium of adult 
skeletal  muscle,  ad,  tunica 
adventitia;  ec,  epicardium; 
em,  endomysium;  mc,  myo- 
cardium;  pc,  pericardium; 
pro, perimysium; sin, smooth 
muscle. Bars: (A-C) 100 ~zm; 
(D) 40 p~m. 
Y-Type FNIII Domains: Is TN-Y a  Young Protein? 
In a  comparative alignment of the most conserved region 
in all tenascins,  the FNIII domain eight and the adjacent 
fibrinogen  globe, we found TN-Y to be more closely re- 
lated to TN-X than to any other tenascin (Chiquet-Ehris- 
mann et al., 1994). This region in TN-Y is as similar to the 
one  of TN-X  as  are  the  corresponding regions  in  TN-C 
and TN-R, indicating that TN-Y and TN-X are paralogous 
(derived  from  a  gene  duplication  before  species  diver- 
gence) rather than orthologous proteins (the same protein 
in different species with sequence differences only reflect- 
ing species divergence) (see Wilson et al., 1977). The close 
relationship between TN-Y and TN-X also holds true for 
the TN-Y FNIII domains YB, YC, YD, and YE which are 
~40--60%  identical  to  the  23  TN-X-type FNIII domains 
(see Bristow et al., 1993; Erickson, 1993), but exhibit only 
~30% identity to FNIII domains in TN-C or TN-R. How- 
ever, there is no clear cotinearity in resemblance of single 
FNIII domains in TN-Y and TN-X as it is the case for do- 
mains 1-8 in TN-C or TN-R orthologues. None of the Y-type 
domains correspond to FNtII domains six or seven which 
are conserved among all other tenascins. 
The FNIII domains YD1 and YE2 occur twice as identi- 
cal  domains  within  the  smallest  TN-Y  variant,  and  do- 
mains YE1, YE3 and YD2 are tandemly repeated several 
times en bloc within the cy6 splice variant. The presence of 
repeated domains which retained 100% nucleotide-sequence 
identity  has  been  reported  only once  before,  for human 
apolipoprotein(a) (McLean et al., 1987). This plasma lipo- 
protein contains 37 copies of the plasminogen kringle 4-like 
unit, 24 being identical in nucleotide sequence. 
It is noteworthy that the series of X-type and Y-type do- 
mains (including the half FNIII domain of TN-Y) are most 
similar to alternatively spliced variable domains of TN-C. 
This suggests that the X- and Y-type FNIII domains and 
maybe all variable domains of the tenascins evolved by du- 
plications of a common precursor domain. Assuming that 
FNIII domains  evolved  at  a  constant  rate  of 1%  amino 
acid  exchange  every 7-9  million  years  (Erickson,  1994), 
duplication  of  the  Y-type  domains  which  are  99-100% 
identical with respect to their amino acid as well as to their 
DNA sequence would have occurred only within the last 9 
million  years.  This  suggests  that  TN-Y evolved  only re- 
cently in evolution. Evidence for recent duplications of the 
Figure 7.  tmmunofluoreseence staining and in situ hybridization of breast muscle from 18-d-old chicken embryos. Consecutive sections 
were stained  with anti-TN-Y (A) and anti-TN-C (B) antibodies or were hybridized to digoxigenin-labeled  anti-sense  riboprobes of TN-Y 
(C and E), TN-C (D) or laminin (F). TN-Y protein (A) and mRNA (C and E) are prominent in the perimysium (pro) and around blood 
vessels but are clearly absent from myofibers (m  f). Diffuse distribution of the TN-Y protein into the tendon (tn) is observed (,4). TN-C 
protein (B) and mRNA (D) are restricted to the tendon (tn) and are prominent around blood vessels. Note that TN-Y and TN-C are co- 
expressed around most blood vessels, but that TN-Y is clearly absent from smooth muscle surrounding arterial vessels where TN-C is 
expressed (arrowhead in all four panels).  Higher magnification shows TN-Y expression by muscle fibroblasts of the perimysium (E) in 
comparison to laminin (F), which is expressed by both muscle fibers and to a lower extent also by muscle fibroblasts.  Bar, 100 p.m. 
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from chicken heart (A) or from conditioned medium of primary 
muscle fibroblasts/myoblasts cocultures (B) was passed over a hep- 
arin-agarose  column.  Samples of  loaded  material  (L),  flow 
through (F), wash (W) and fractions eluted with 1 M NaC1 (num- 
bered)  were  analyzed by immunoblotting  using the  anti-TN-Y 
antibody.  The  ~400-kD and  ~300-kD  variants  of TN-Y from 
heart and the ~220- and ,~170-kD variants of TN-Y from condi- 
tioned medium were recovered in the high salt fractions (arrow- 
heads point  to  high-molecular  mass doublets,  arrows indicate 
low-molecular mass variants). Protein marker sizes are indicated 
by dashes (in kD) from top to bottom: 200,155, 115, 97, and 66 kD. 
variable  FNIII domain A  within  the  human TN-C gene 
(Gulcher et al., 1990) points to a high mobility and proba- 
bility to duplicate as a characteristic feature of the variable 
domains. 
Database searches with the FNIII domain YA did not 
reveal significant homology to other FNIII domains of te- 
nascins.  Interestingly,  with  27%  identity,  the  FNIII do- 
main 14 of fibronectin was the most homologous domain 
Figure 10.  Secretion of TN-Y by cocultured  muscle fibroblasts 
and myoblasts in medium containing HS. (A and B) Conditioned 
media from cells grown with 10% FCS (lanes 1) or with 10% HS 
(lanes 2)  were  analyzed on Western  blots which were  stained 
with amido black (A)  and  incubated  with anti-TN-Y antibody 
(B). The ~220-kD  (black arrowhead) and the ~170 kD (arrow) 
variants of TN-Y are only released into the culture medium by 
cells grown in medium containing 10% HS (B, lane 2). (C) Immu- 
noblot of purified TN-Y from conditioned medium separated on 
a 3-15%  gradient  SDS-polyacrylamide gel under  reducing (+) 
and non-reducing (-) conditions. A high-molecular mass variant 
barely enters the gel under non-reducing conditions (open arrow- 
head), while the ~220-kD variant (black arrowhead) disappears. 
The ~170-kD variant remains at the same position under both 
conditions. Protein marker sizes are given in kilodalton. 
found. Since domain YA is only ~20% identical to FNIII 
domain 1 in TN-C or TN-X, respectively, it is possible that 
the FNIII domains of TN-Y were assembled from differ- 
ent  sources.  A  mechanism by which this  could have oc- 
curred is exon shuffling (Gilbert, 1978). This mechanism is 
thought to be promoted by class  1 introns (that split the 
codon after the first position) flanking the exons (Patthy, 
1991), the type of junction indeed found in TN-Y. 
Like in TN-C and TN-R, alternative splicing of FNIII 
domains creates different variants of TN-Y. The TN-Y iso- 
forms produced by muscle fibroblasts in  cell  culture  are 
markedly smaller than those isolated from chicken heart 
extracts.  Similarly,  size  differences  between  transcripts 
produced by cells in culture and those isolated from tissue 
were also found for TN-X (Matsumoto et al.,  1994). Dis- 
tinct environmental influences could affect mRNA splic- 
ing of cultured cells.  This and the different sets of cDNA 
clones point to a complex pattern of alternative splicing of 
the Y-type FNIII domains. 
TN-X and TN-Y: Structural Paralogues but 
Functional Homologues? 
As pointed out earlier, TN-Y and TN-X cannot be consid- 
ered as orthologues from the structural point of view, since 
they are clearly more distinct from each other than for ex- 
ample  chicken  and  mammalian  TN-C, but  nevertheless, 
they share many common features.  They are  the  largest 
proteins of the  tenascin family, and  their FNIII domains 
are of longer average size than those in TN-C and TN-R 
and lack any glycosylation sites (see Bristow et al.,  1993). 
However, the most striking common feature of TN-X and 
TN-Y is their predominant expression in skeletal  muscle 
and heart tissue, where the proteins and transcripts of both 
molecules are found in corresponding regions of muscle- 
associated connective tissue in mouse (Matsumoto et al., 
1994; Burch et al.,  1995)  and chicken, respectively. From 
our in situ data and from observations in cell  cultures we 
conclude that TN-Y is expressed by fibroblasts of the mus- 
cle connective tissue but not by muscle cells,  although we 
cannot exclude that muscle fiber-associated satellite cells 
are an additional source of TN-Y. Non-myocyte cell types 
were  also found to  be  the  major source of TN-X in  rat 
muscle (Burch et al., 1995). Fibroblasts between muscle fi- 
bers do not normally express TN-C, but are positive for 
TN-Y in chicken (and for TN-X in rodents). Conversely, 
tendon fibroblasts and fibroblasts near the myotendinous 
junction produce TN-C (Chiquet and Fambrough 1984a). 
This suggests that the different, specialized connective tis- 
sue compartments associated with muscle are marked by 
the presence of at least two different types of fibroblasts. 
In skeletal muscle, TN-Y expression is associated with 
the "late" period of myoblast development, i.e.,  with the 
accumulation  of secondary and  adult  myotubes (Stock- 
dale,  1992)  which is  associated with dramatic changes in 
muscle-associated  connective  tissue  (Fernandez  et  al., 
1991).  TN-Y expression in heart coincides with terminal 
steps in compartmentalization at a  time where the heart 
function  is  already  well  established  (around  embryonic 
day 8), and persists during the period of enlargement and 
thickening  of heart  muscular  structures  (see  Romanoff, 
1960).  Another  common feature  of TN-Y  and  TN-X is 
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smooth muscle wall (tunica media), where TN-C is strongly 
expressed (Burch et al., 1995). Here, TN-Y in chicken and 
TN-X in rodents are present in the tunica adventitia, that 
surrounds the smooth muscle as a loose connective tissue 
layer and anchors the vessel to the adjacent tissue (Morse, 
1979). 
These data suggest a role for TN-Y in the establishment 
of connective  tissue  layers  in  and  around skeletal,  heart 
and smooth muscle in the chicken embryo, and the main- 
tenance of these patterns throughout adult life.  A  similar 
suggestion  has  been  made  for  the  function  of  TN-X 
(Burch et al., 1995).  The ubiquitous distribution of TN-Y 
and TN-X within these tissues make them potential candi- 
dates to be involved in anchoring muscle fibers to the sur- 
rounding matrix.  Since both TN-Y  and TN-X  have been 
shown to bind to heparin, this link could at least partially 
be mediated through interaction with heparan-sulfate pro- 
teoglycans present  in the endomysium (Fernandez et al., 
1991). 
TN-X has been mapped to the major histocompatibility 
complex  (MHC)  class  III  region  in  human  and  mouse 
(Matsumoto et al.,  1992,  1994)  which is part of the MHC 
locus  that  comprises  MHC  I,  MHC  II,  and MHC  III  in 
mammals. However, there is no evidence for the existence 
of a  class  III region within the  avian MHC locus, which 
seems to have been stripped down to a "minimal essential 
MHC" with respect to immune function (Kaufman et al., 
1995).  Up  to now, none of the  genes  present  within  the 
mammalian  MHC  III  region  have  been  identified  in 
chicken. In fact, the whole avian genome has been reduced 
during  evolution, comprising  only roughly a  third  of the 
size of a typical mammalian genome, and is split into few 
macrochromosomes and  a  number of minichromosomes 
(reviewed in Burt et al.,  1995).  The possibility  exists that 
the class III region was lost from the  avian genome  en- 
tirely. In this case chickens would lack a TN-X orthologue, 
and TN-Y could have evolved in replacement of TN-X in 
mammals. Thus it is possible that, although TN-Y and TN-X 
are not orthologous proteins, they serve equivalent func- 
tions in birds and mammals. So far, there is no evidence 
for a TN-X gene in birds or a TN-Y gene in mammals, re- 
spectively. Further studies are needed to clarify the evolu- 
tionary and functional relationship between the two pro- 
teins. 
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